{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:08:42Z","timestamp":1787022522811,"version":"build-2736575974"},"reference-count":46,"publisher":"Walter de Gruyter GmbH","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>We evaluated the (pre-)analytical and diagnostic performance of two automated fecal calprotectin (FC) immunoassays, Liaison<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Our study comprised 229 consecutive patients with clinical suspicion of inflammatory bowel disease (IBD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>All assay related stool extraction procedures showed excellent correlation with the established method, but the new stool extraction devices tend to give higher results as compared with stool weight methods. Both automated assays demonstrated good performance in terms of precision (CV<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In conclusion, the newly developed stool extraction device protocols showed acceptable and comparable performance to the stool weight method. Overall, the automated Liaison<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/cclm-2016-0796","type":"journal-article","created":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T05:00:53Z","timestamp":1484110853000},"source":"Crossref","is-referenced-by-count":27,"title":["Analytical and diagnostic performance of two automated fecal calprotectin immunoassays for detection of inflammatory bowel disease"],"prefix":"10.1515","volume":"55","author":[{"given":"Maxime M.W.","family":"De Sloovere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"De Smet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip J.","family":"Baert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Debrabandere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde J.M.","family":"Vanpoucke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","reference":[{"key":"ref411","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3109\/00365513.2015.1030765","article-title":"Validation of a new extraction device for measuring faecal calprotectin in inflammatory bowel disease, and comparison to established extraction methods","volume":"75","year":"2015","journal-title":"Scand J Clin Lab Invest"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4291\/wjgp.v6.i4.203","article-title":"Faecal calprotectin: management in inflammatory bowel disease","volume":"6","year":"2015","journal-title":"World J Gastrointest Pathophysiol"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3109\/00365513.2015.1030765","article-title":"Validation of a new extraction device for measuring faecal calprotectin in inflammatory bowel disease, and comparison to established extraction methods","volume":"75","year":"2015","journal-title":"Scand J Clin Lab Invest"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3109\/00365529709011203","article-title":"Stool form scale as a useful guide to intestinal transit time","volume":"32","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1002\/ibd.21257","article-title":"Diagnostic work-up of inflammatory bowel disease in children: the role of calprotectin assay","volume":"16","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"ref451","first-page":"41","article-title":"Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16\u201350 years","volume":"9","year":"2015","journal-title":"J Crohns Colitis"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/0895-4356(91)90128-V","article-title":"Likelihood ratios with confidence: sample size estimation for diagnostic test studies","volume":"44","year":"1991","journal-title":"J Clin Epidemiol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.crohns.2012.09.003","article-title":"Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis","volume":"6","year":"2012","journal-title":"J Crohns colitis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ibd.21048","article-title":"World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010","volume":"16","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1515\/cclm-2013-0699","article-title":"Comparison of two immunoassays for measurement of faecal calprotectin in detection of inflammatory bowel disease: (pre)-analytical and diagnostic performance characteristics","volume":"52","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.dld.2008.05.008","article-title":"Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease","volume":"41","year":"2009","journal-title":"Dig Liver Dis"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/0003-4819-138-1-200301070-00012-w1","article-title":"The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration","volume":"138","year":"2003","journal-title":"Ann Intern Med"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.clinbiochem.2015.10.010","article-title":"Comparison of the Liaison(R) Calprotectin kit with a well established point of care test (Quantum Blue \u2013 Buhlmann-Alere(R)) in terms of analytical performances and ability to detect relapses amongst a Crohn population in follow-up","volume":"49","year":"2016","journal-title":"Clin Biochem"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/0895-4356(91)90128-V","article-title":"Likelihood ratios with confidence: sample size estimation for diagnostic test studies","volume":"44","year":"1991","journal-title":"J Clin Epidemiol"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/MIB.0b013e3182802b6e","article-title":"A new rapid quantitative test for fecal calprotectin predicts endoscopic activity in ulcerative colitis","volume":"19","year":"2013","journal-title":"Inflamm Bow Dis"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1515\/cclm-2012-0386","article-title":"Faecal calprotectin: comparative study of the Quantum Blue rapid test and an established ELISA method","volume":"51","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ibd.21048","article-title":"World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010","volume":"16","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.crohns.2012.09.003","article-title":"Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis","volume":"6","year":"2012","journal-title":"J Crohns colitis"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1572-0241.2007.01126.x","article-title":"Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy","volume":"102","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1002\/ibd.21257","article-title":"Diagnostic work-up of inflammatory bowel disease in children: the role of calprotectin assay","volume":"16","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cca.2012.11.008","article-title":"Monoclonal antibody testing for fecal calprotectin is superior to polyclonal testing of fecal calprotectin and lactoferrin to identify organic intestinal disease in patients with abdominal discomfort","volume":"416","year":"2013","journal-title":"Clin Chim Acta"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4291\/wjgp.v6.i4.203","article-title":"Faecal calprotectin: management in inflammatory bowel disease","volume":"6","year":"2015","journal-title":"World J Gastrointest Pathophysiol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0009-8981(99)00206-5","article-title":"Improved assay for fecal calprotectin","volume":"292","year":"2000","journal-title":"Clin Chim Acta"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1515\/cclm-2012-0386","article-title":"Faecal calprotectin: comparative study of the Quantum Blue rapid test and an established ELISA method","volume":"51","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/MIB.0b013e3182802b6e","article-title":"A new rapid quantitative test for fecal calprotectin predicts endoscopic activity in ulcerative colitis","volume":"19","year":"2013","journal-title":"Inflamm Bow Dis"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/00054725-200606000-00013","article-title":"Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease","volume":"12","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0009-8981(99)00206-5","article-title":"Improved assay for fecal calprotectin","volume":"292","year":"2000","journal-title":"Clin Chim Acta"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3748\/wjg.v20.i2.363","article-title":"Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome","volume":"20","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.crohns.2009.09.009","article-title":"The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations","volume":"4","year":"2010","journal-title":"J Crohns Colitis"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.dld.2008.05.008","article-title":"Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease","volume":"41","year":"2009","journal-title":"Dig Liver Dis"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cca.2012.11.008","article-title":"Monoclonal antibody testing for fecal calprotectin is superior to polyclonal testing of fecal calprotectin and lactoferrin to identify organic intestinal disease in patients with abdominal discomfort","volume":"416","year":"2013","journal-title":"Clin Chim Acta"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.crohns.2009.09.009","article-title":"The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations","volume":"4","year":"2010","journal-title":"J Crohns Colitis"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1572-0241.2007.01126.x","article-title":"Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy","volume":"102","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3109\/00365529209011186","article-title":"Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study","volume":"27","year":"1992","journal-title":"Scand J Gastroenterol"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3109\/00365529209011186","article-title":"Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study","volume":"27","year":"1992","journal-title":"Scand J Gastroenterol"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3109\/00365529709011203","article-title":"Stool form scale as a useful guide to intestinal transit time","volume":"32","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1258\/acb.2012.011272","article-title":"Between-assay variability of faecal calprotectin enzyme-linked immunosorbent assay kits","volume":"50","year":"2013","journal-title":"Ann Clin Biochem"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","year":"1988","journal-title":"Biometrics"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/0003-4819-138-1-200301070-00012-w1","article-title":"The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration","volume":"138","year":"2003","journal-title":"Ann Intern Med"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1258\/acb.2012.011272","article-title":"Between-assay variability of faecal calprotectin enzyme-linked immunosorbent assay kits","volume":"50","year":"2013","journal-title":"Ann Clin Biochem"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1515\/cclm-2013-0699","article-title":"Comparison of two immunoassays for measurement of faecal calprotectin in detection of inflammatory bowel disease: (pre)-analytical and diagnostic performance characteristics","volume":"52","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3748\/wjg.v20.i2.363","article-title":"Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome","volume":"20","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/00054725-200606000-00013","article-title":"Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease","volume":"12","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","year":"1988","journal-title":"Biometrics"},{"key":"ref221","first-page":"41","article-title":"Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16\u201350 years","volume":"9","year":"2015","journal-title":"J Crohns Colitis"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.clinbiochem.2015.10.010","article-title":"Comparison of the Liaison(R) Calprotectin kit with a well established point of care test (Quantum Blue \u2013 Buhlmann-Alere(R)) in terms of analytical performances and ability to detect relapses amongst a Crohn population in follow-up","volume":"49","year":"2016","journal-title":"Clin Biochem"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/cclm.2017.55.issue-9\/cclm-2016-0796\/cclm-2016-0796.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2016-0796\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T03:43:17Z","timestamp":1658374997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2016-0796\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,1]]},"references-count":46,"journal-issue":{"issue":"9"},"URL":"https:\/\/doi.org\/10.1515\/cclm-2016-0796","relation":{},"ISSN":["1437-4331","1434-6621"],"issn-type":[{"value":"1437-4331","type":"electronic"},{"value":"1434-6621","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1,1]]}}}